A recent blog post from AMSBIO introduces a selection of the ‘green products’ it offers to life science researchers looking to maintain rigorous scientific standards in their lab whilst also trying to minimize environmental impact.
Laboratories are known to consume a significant amount of energy and produce a considerable amount of waste. However, with the increasing awareness of the importance of sustainability, many life sciences labs are taking steps towards prioritizing sustainable products and practices.
AMSBIO offers a growing range of products including collagenase, exosome standards,…
Guest Blog: Ahead of BioBeat23, Miranda Weston-Smith, BioBeat founder, talks to Alisa Molotova, Investment Manager at Martlet and co-organiser of BioBeat23 about her investment journey.
Miranda: It’s a total pleasure working with you on BioBeat23: Out of adversity comes opportunity on 18 May at the Cambridge Union. I’m curious to know, how did you get into biotech investing?
Alisa: I spent years in the lab studying the intricacies of cellular biology and regenerative medicine. It was a fascinating field, but I soon realised that my passion for science extended beyond the lab…
There is no doubt that AI is a revolution underway, not just in healthcare, but across a broad range of industries. Although, continuing improvements in technology capabilities, such as computing power, and access to data are creating more opportunities for the application of AI in the drug discovery process, Pharma still lags behind other industries for AI adoption. It is interesting to see therefore, the recent UK Government announcement for a 10-year Quantum Strategy, which sees the promise of £2.5bn of Government funding to fuel the use of quantum technologies. When it comes to…
Global life expectancy at birth increased from 66.8 years in 2000 to 73.3 years compared to 2019, and healthy life expectancy at birth increased from 58.3 years to 63.7 years. However, the pandemic has had a detrimental impact on life expectancy and healthy life expectancy and global inequalities remain a challenge. [World Health Statistics 2022, WHO]
Whilst the data confirms that we are living longer, those years are not necessarily spent in good health. The pandemic was a significant cause of an increase in mortality, but as we age the risk of chronic diseases, such as diabetes,…
Guest blog by Naomi Vowles at Sookio
Google Analytics 4 (GA4) is the new generation of Google Analytics. This invaluable tool is a new way of tracking activity on your website.
In July 2023, Google will stop tracking website data on Universal Analytics - so now is the time to get prepared to make the switch!
But where do you begin? Read on to discover the essential steps for getting started with GA4…
1. Find out how Google Analytics 4 (GA4) works
This is an important first step for anyone transitioning to GA4. Google Analytics works by collecting…
We had a great time at the Bradfield Centre, Cambridge Science Park at our BioWednesday on 1 February in collaboration with Appleyard Lees IP LLP discussing 'How do Investors and Entrepreneurs Evaluate Intellectual Property?' 50 delegates joined to listen to the discussion and to enjoy some informal networking afterwards. Many thanks to our moderator Edward Rainsford, Appleyard Lees and our expert panellists: Alison McGhee, AstraZeneca; Mike Romanos, Imperial College London; Anne Horgan (nee Nguyen), Cambridge Innovation Capital and Iain Thomas, Cambridge Enterprise.
I am pleased to share…
Our Annual Review is a highly anticipated review of the year including a narrative on One Nucleus services, relevant articles and adverts for the Cambridge Life Science ecosystem as well as our member listing. You can join our influential sponsors by taking out an A4 advert for a great profiling opportunity for your organisation.
The idea of the advert is to showcase your company to our other members and wider network. The recipient profile is similar to the profile for all our activities and membership profile, as illustrated below:
For 2023 we are planning to publish the Annual Review on…
Guest blog by Estelle Roger, Precision for Medicine
Research & Development (R&D) Tax Credits are available to pharma and biotechs to incentivize drug development and clinical research in countries around the world
In this article, we will discuss the United Kingdom’s R&D tax credit program, which is part of its post-Brexit strategy to boost innovation in drug development within its borders. First, a bit of information about Precision for Medicine. We are more than just a Contract Research Organization and have a comprehensive suite of capabilities to support the spectrum…
Guest Blog Post by Sura Hussein, Senior Business Development Manager, London & Partners
Reflecting on the fabulous One Nucleus event last week #Genesis2022 I wanted to share some notes on the panel discussing the key ingredients for a successful Life sciences cluster.
The stage was an upbeat debate with the playful title which was Cambridge UK vs Cambridge MA / USA.
The Debaters were: Catherine Stace, Domainex, Max Bryan, Bidwells, John McCafferty, Maxion Therapeutics, Nick Foster, Metrion Biosciences, Jiahao Huang, Nuclera – chaired by Mike Ward, Clarivate
Taking that I am bias for…
Guest article by RSM UK
There is growing consensus that the UK economy will remain in recession through much of 2023.
We asked our panel of middle market business leaders how prepared they feel for the oncoming difficulties.
Explore the findings
If you would like to submit a guest blog or article, please contact natalie@onenucleus.com